APA (7th ed.) Citation

R, A., M, W., T, F., M, H., S, K., & S, M. (2026). Encephalopathy Post CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma: Beyond ICANS. Journal of investigative medicine high impact case reports, 14, 23247096261478903. https://doi.org/10.1177/23247096261478903

Chicago Style (17th ed.) Citation

R, Ahmad, Wild M, Friesen T, Hall M, Kouba S, and Maliske S. "Encephalopathy Post CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma: Beyond ICANS." Journal of Investigative Medicine High Impact Case Reports 14 (2026): 23247096261478903. https://doi.org/10.1177/23247096261478903.

MLA (9th ed.) Citation

R, Ahmad, et al. "Encephalopathy Post CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma: Beyond ICANS." Journal of Investigative Medicine High Impact Case Reports, vol. 14, 2026, p. 23247096261478903, https://doi.org/10.1177/23247096261478903.